EXPAND AND CONSOLIDATE GLOBAL FOOTPRINT

to provide access to quality medicines at an affordable price

Konw More

About IMSDA

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Konw More

In The News

CDSCO Moves to Ban Same Brand, Different Drug Practice in India - What This Means for Generic Medicine Buyers For international buyers and procurement professionals sourcing generic medicines from India, this regulatory direction has several practical implications: Brand-name reliance is decreasing as a safe procurement strategy. Buyers who source by brand name alone should now factor in that CDSCO is actively working to restrict how brand names […]
iPHEX 2026: 600+ Global Delegates Set to Source from India’s Pharma Sector - What This Means for Buyers of Indian Generic Medicines For healthcare procurement professionals, distributors, and pharmacy chain buyers, iPHEX 2026 represents a concentrated opportunity to: Evaluate multiple Indian generic medicine suppliers in a single venue Discuss WHO-GMP and CDSCO compliance documentation directly with manufacturers Explore pricing structures for high-volume generic categories including cardiovascular, diabetes, and […]
CDSCO Orders Pharma Firms to Maintain ADR Reporting Systems - The Central Drugs Standard Control Organization (CDSCO) has directed all pharmaceutical companies operating in India to establish and maintain robust adverse event (AE) reporting systems and pharmacovigilance (PV) programs for their marketed drug products, as reported by The Economic Times and Medical Dialogues in early June 2026. What CDSCO Directed In a significant regulatory move, […]
India Pushes for Pharma Market Access in Argentina and Brazil - What This Means for Buyers For buyers of Indian generic medicines, the South America push signals several practical developments: More competitive pricing — as Indian manufacturers gain access to larger regional markets, economies of scale could drive down prices for commonly prescribed generics, including cardiovascular drugs, antibiotics, and diabetes medications. Expanded product availability — Indian […]
Read More

Our Videos

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Konw More

Stay Connected

If you have any question,please connect us.

Connect Us

Join Us

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Join Us